Minerva Neurosciences to Report Third Quarter 2019 Financial Results and Business Updates on November 4, 2019
WALTHAM, Mass., Oct. 28, 2019 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the […]